Angels Partners logo
  • Find Angel Investors
    • Find Angel Investors in the US
    • Find Angel Investors in the UK
    • Find Angel Investors in Europe
      Find Angel Investors in DenmarkFind Angel Investors in FinlandFind Angel Investors in FranceFind Angel Investors in GermanyFind Angel Investors in ItalyFind Angel Investors in NetherlandsFind Angel Investors in SwedenFind Angel Investors in Switzerland
    • Find Angel Investors in Canada
    • Find Angel Investors in Australia
  • Top VC Firms
    Top AI VC firmsTop BioTech VC firmsTop CleanTech VC firmsTop Cyber Security VC firmsTop E-commerce VC firmsTop HealthTech VC firmsTop FinTech VC firmsTop Food Industry VC firmsTop Robotics VC firmsTop SaaS VC firmsTop Transportation VC firms
  • Pricing
  • Products
    Investor CommunityInvestor DatabaseAutomationWarm IntrosFounder CommunityDocument SharingLegal Templates
  • FAQ
  • Blog
  • About
  • Sign up
  • Log in
Are you an

  • Entrepreneur
  • Investor
< Browse Firms
Logo Firm Medicxi
websitegoogle

Medicxi

map marker logo London London, United Kingdom with regional offices in Geneva - U.K. |  U.K.

Investor TypeFirm
Type of FundVenture Capital Fund
IndustriesSoftware (Web Marketplace Saas..) • BioTech • Businesses Solutions • Hardware (& Manufacturing) • Food & Beverage • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Life Science • Nanotechnology • Oncology • Pharmaceutical (& Medicine)
StagesSeed, Startup, Early Stage, Expansion, Later Stage
InvestingUnited Kingdom • Switzerland • Europe
Assets Under Management $500,000,000

Investors who are part of this firm

About The Fund

Medicxi is a life sciences-focused venture capital firm with a profound orientation towards healthcare, biotechnology, and the pharmaceutical sector. Established in 2016 and headquartered in London, United Kingdom, Medicxi operates on a philosophy of supporting innovation in the life sciences domain. With additional offices in Geneva, Switzerland, and Saint Helier, United Kingdom, the firm's geographic footprint underpins its strategic investments across different hubs of scientific and entrepreneurial activity within its sector focus. Medicxi specializes in equity investments, catering to various stages of business development, including seed, startup, early stage, expansion, and later stage ventures. The fund manages assets worth $500 million, which is indicative of substantial financial capabilities to drive and support groundbreaking advancements in life sciences. Medicxi’s investment thesis anchors on identifying and nurturing high-potential enterprises that are poised to redefine the realms of biotech, academia, and pharmaceuticals. Their portfolio encapsulates a broad spectrum of industries including Software focusing on Web Marketplace SaaS, BioTech, Business Solutions, Hardware and Manufacturing, Food and Beverage, Logistics and Distribution, Medical Devices and Hospital Services, Life Science, Nanotechnology, Oncology, and Pharmaceutical and Medicine. Medicxi’s commitment to innovation is evident in their backing of ventures such as Ottimo Pharma, which recently raised over $140 million in Series A funding to develop novel bi-functional antibodies. They also hold stakes in Vicebio, which has initiated Phase 1 Clinical Study for an RSV/hMPV Bivalent Vaccine, and Levicept, which announced positive results of a Phase II trial of a new Neurotrophin-3 Inhibitor for osteoarthritis treatment. Medicxi’s approach combines financial investment with strategic guidance, leveraging the firm’s expertise and networks to maximize the potential of their investee companies.

Medicxi's investments on record

SutroVax  
SynOx Therapeutics $43,560,000.00 Later stage VC
Divide & Conquer $12,270,000.00 Later stage VC

Similar Investment Firms

Similar Investor RD Capital Partners
RD Capital Partners
Similar Investor The Royal Society of London
The Royal Society of London
Similar Investor Plutus PowerGen
Plutus PowerGen
Similar Investor Syncona
Syncona
Similar Investor Abingworth Management
Abingworth Management
Similar Investor NVM Private Equity Ltd.
NVM Private Equity Ltd.
Similar Investor RLC Ventures
RLC Ventures
Similar Investor Fintex Capital
Fintex Capital
Similar Investor FPE Capital
FPE Capital
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

e We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

  • Sign up
  • Log in
  • Prime Founders
  • 85 Great Portland St.
  • London, U.K.
  •   contact@angelspartners.com
  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Editorial Process
  • Contact Us
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 daysproof logo